TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Idexx Laboratories Sverige AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
165,653
|
158,174
|
139,570 |
| Financial expenses |
14
|
9
|
5 |
| Earnings before taxes |
4,285
|
2,485
|
2,012 |
| EBITDA |
4,460
|
2,884
|
2,947 |
| Total assets |
54,643
|
44,120
|
29,478 |
| Current assets |
47,209
|
39,452
|
24,856 |
| Current liabilities |
29,693
|
22,117
|
10,722 |
| Equity capital |
24,950
|
22,003
|
18,757 |
| - share capital |
52
|
51
|
47 |
| Employees (average) |
20
|
20
|
17 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
45.7%
|
49.9%
|
63.6% |
| Turnover per employee |
8,283
|
7,909
|
8,210 |
| Profit as a percentage of turnover |
2.6%
|
1.6%
|
1.4% |
| Return on assets (ROA) |
7.9%
|
5.7%
|
6.8% |
| Current ratio |
159.0%
|
178.4%
|
231.8% |
| Return on equity (ROE) |
17.2%
|
11.3%
|
10.7% |
| Change turnover |
4,627
|
8,700
|
18,538 |
| Change turnover % |
3%
|
6%
|
15% |
| Chg. No. of employees |
0
|
3
|
0 |
| Chg. No. of employees % |
0%
|
18%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.